FILTER
LATEST INTERVIEWS
Paul Everingham
CEO, Chamber of Mines and Energy for Western Australia (CME)
The Chamber of Minerals and Energy of Western Australia (CME) is the peak resources sector representative body in Western Australia.
Christophe Fleurence
VICE PRESIDENT, BUSINESS DEVELOPMENT AFRICA, TOTAL EREN
Total Eren develops, finances, invests in, builds and operates renewable energy power plants at a global level.
William Witham
CEO, AUSTRALIA-AFRICA MINERALS & ENERGY GROUP (AAMEG)
The Australia-Africa Minerals & Energy Group is the peak body representing Australian companies engaged in the development of Africa’s resource industry.
Stan Wholley
PRESIDENT - AMERICAS, CSA GLOBAL
CSA Global provides technical and expert services, training and independent corporate advice to the mining industry.
Dany Pelletier & Serge Cotes
VICE PRESIDENT, STRUCTURING CAPITAL, ENERGY, ENVIRONMENT AND MINING & SENIOR INVESTMENT ADVISOR: FONDS DE SOLIDARITÉ FTQ.
The Fonds de solidarité FTQ is a Québec development capital organization dedicated to investing in local businesses to further economic development.
Jörgen Sjöstedt
MANAGING DIRECTOR, VOLVO GROUP PERU
Volvo Group Peru is expanding its market share in the region and increasingly focused on opportunities in the construction segment.
Tom Revy
MANAGING DIRECTOR, BLACKEARTH MINERALS
BlackEarth Minerals is a mineral exploration and development company targeting assets around the world rich in high-value graphite.
Jim Neal
CEO, XOMA
XOMA is a royalty monetizer acquiring early clinical-stage milestone and royalty assets.
David Kelley
CEO, CHAKANA COPPER CORP.
Chakana Copper is progressing its Soledad project with a planned drilling campaign of 20,000 meters.
Julio Garcia
OWNER AND GENERAL MANAGER, ADIZOL
ADIZOL is the distributor for the global specialty chemicals company Lubrizol in Chile, where the lubricant and fuel markets remain key.
MACIG
SPANISH
SUBSCRIBE TO OUR NEWSLETTER
RECENT PUBLICATIONS
United States Life Sciences 2025 - Digital Interactive
Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
PARTNER EVENTS
SUBSCRIBE TO OUR
NEWSLETTER
- Get GBR content delivered to your inbox
- Receive industry based news
- Completely free, e-mail only
